Semax and selank: separating Russian research from TikTok hype
Quick answer
Semax and selank are synthetic peptides with some preclinical and small-scale human data supporting cognitive and anxiolytic effects respectively, but neither has FDA approval or robust randomized controlled trial evidence in healthy adults. The creator's dismissal reflects a defensible read of a thin evidence base, but their recommended alternatives carry risks the video does not disclose. Anyone exploring these compounds should do so under medical supervision given the unresolved regulatory and safety questions.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @androgenic_ actually say?
The creator dismissed semax and selank as low-value peptides, arguing that "there are so many better ways" to increase BDNF and neurogenesis. They pointed to alternatives including cerebrolysin, low-to-moderate dose psychedelics, and compounds they describe as positive allosteric modulators of TrkB and AMPA receptors. For selank, they were equally dismissive of its anti-anxiety use, and closed with a pointed line: the main reason you don't get dependent on selank is "because it's not really doing much for you."
This is a confident, sweeping dismissal. Some of it holds up. Some of it oversimplifies a genuinely complicated evidence base, and a few of the "better" alternatives they recommend carry risk profiles the video never acknowledges.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 3 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Semax and selank: separating Russian research from TikTok hype, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Functional Connectomic Approach to Studying Selank and Semax Effects
Small Russian fMRI study (52 healthy volunteers) of brain connectivity after Semax or Selank; mechanistic and exploratory, not a clinical efficacy trial.
PubMed
Effects of Semax on the Default Mode Network of the Brain
Small human fMRI study (24 adults) of intranasal Semax on brain networks; an imaging-marker study with no clinical outcomes, not replicated outside the originating group.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Semax and selank: separating Russian research from TikTok hype is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
Semax and selank are synthetic peptides with some preclinical and small-scale human data supporting cognitive and anxiolytic effects respectively, but neither has FDA approval or robust randomized controlled trial evidence in healthy adults.
FormBlends verdict
Semax and selank are synthetic peptides with some preclinical and small-scale human data supporting cognitive and anxiolytic effects respectively, but neither has FDA approval or robust randomized controlled trial evidence in healthy adults. The creator's dismissal reflects a defensible read of a thin evidence base, but their recommended alternatives carry risks the video does not disclose. Anyone exploring these compounds should do so under medical supervision given the unresolved regulatory and safety questions.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Semax and selank are synthetic peptides with some preclinical and small-scale human data supporting cognitive and anxiolytic effects respectively, but neither has FDA approval or robust randomized controlled trial evidence in healthy adults. The creator's dismissal reflects a defensible read of a thin evidence base, but their recommended alternatives carry risks the video does not disclose. Anyone exploring these compounds should do so under medical supervision given the unresolved regulatory and safety questions.
- Semax has documented BDNF upregulation in animal models (Dolotov et al., 2014), but no large randomized controlled trials in healthy adults exist to support routine cognitive optimization use.
- Selank shows anxiolytic effects in preclinical models with some GABAergic activity (Semenova et al., 2010), but human data remains limited and not independently replicated at Western regulatory standards.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Semax has documented BDNF upregulation in animal models (Dolotov et al., 2014), but no large randomized controlled trials in healthy adults exist to support routine cognitive optimization use.
- Selank shows anxiolytic effects in preclinical models with some GABAergic activity (Semenova et al., 2010), but human data remains limited and not independently replicated at Western regulatory standards.
- Neither semax nor selank is FDA approved. Both exist in a compounding gray zone in the US with unresolved regulatory status.
- Cerebrolysin, offered as a superior alternative, received a mixed finding in a 2020 Cochrane review, which found insufficient evidence to broadly recommend it for cognitive impairment.
- Psychedelics carry Schedule I legal status in the US and documented psychological risk outside clinical settings. Presenting them as a simple upgrade over injectable peptides without those caveats is incomplete.
- Low dependency risk in selank reflects its pharmacological mechanism, not proof of inefficacy. The creator's logic on this point does not hold up to basic pharmacology.
- Anyone considering semax, selank, or any of the alternatives named in this video should consult a licensed clinician. The evidence base for all of these compounds in healthy adults is thinner than confident social media takes suggest.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
androgenic · TikTok creator
117.0K views on this video
Semax and selank?
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by androgenic, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.